• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喷雾干燥法提高塞来昔布溶解度的研究

The use of spray-drying to enhance celecoxib solubility.

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

出版信息

Drug Dev Ind Pharm. 2011 Dec;37(12):1463-72. doi: 10.3109/03639045.2011.587428. Epub 2011 Jun 27.

DOI:10.3109/03639045.2011.587428
PMID:21707230
Abstract

The present research investigates the enhancement of the dissolution rate of celecoxib by using spray-drying to prepare a solid dispersion with various polymers, namely Kollicoat IR® (Kollicoat), polyvinyl alcohol (PVA) 22000, or polyethylene glycol 6000 (PEG). The investigated drug-to-polymer mass ratios were 1:1, 1:2, and 1:4 by weight. Hydroalcoholic or methylene chloride solvent systems were used. The obtained yields ranged from 65% to 78%, whereas the entrapment efficiencies were between 68% and 82%. The results revealed an increase in the dissolution rate of the prepared particles up to 200% within 20 min. The prepared particles were investigated using differential scanning calorimetry, scanning electron microscopy, X-ray diffraction, and Fourier transform infrared spectroscopy. The increased dissolution rate was attributed to hydrogen bond formation between celecoxib and each polymer together with the reduced size of the formed particles offering a greater overall surface area. It was concluded that spray-drying may be considered a successful one-step technique to improve the dissolution rate of celecoxib when using Kollicoat, PVA, or PEG as the carrier polymer.

摘要

本研究通过喷雾干燥法制备了 Celecoxib 的固体分散体,使用了不同的聚合物,即 Kollicoat IR®(Kollicoat)、聚乙烯醇(PVA)22000 或聚乙二醇 6000(PEG),以提高其溶解速率。研究了药物与聚合物的质量比分别为 1:1、1:2 和 1:4。使用了水醇或二氯甲烷溶剂体系。获得的产率在 65%至 78%之间,而包封效率在 68%至 82%之间。结果表明,在 20 分钟内,制备的颗粒的溶解速率提高了 200%。使用差示扫描量热法、扫描电子显微镜、X 射线衍射和傅里叶变换红外光谱对制备的颗粒进行了研究。溶解速率的提高归因于 Celecoxib 与每种聚合物之间形成氢键以及形成的颗粒尺寸减小,从而提供了更大的总表面积。结论是,当使用 Kollicoat、PVA 或 PEG 作为载体聚合物时,喷雾干燥可以被认为是一种提高 Celecoxib 溶解速率的成功的一步法技术。

相似文献

1
The use of spray-drying to enhance celecoxib solubility.喷雾干燥法提高塞来昔布溶解度的研究
Drug Dev Ind Pharm. 2011 Dec;37(12):1463-72. doi: 10.3109/03639045.2011.587428. Epub 2011 Jun 27.
2
Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.含储存和压缩稳定剂的无定形塞来昔布喷雾干燥共沉淀物的研制
Acta Pharm. 2007 Sep;57(3):287-300. doi: 10.2478/v10007-007-0023-7.
3
Fabrication and evaluation of celecoxib microparticle surface modified by hydrophilic cellulose and surfactant.亲水性纤维素和表面活性剂修饰的塞来昔布微粒的制备与评价
Int J Biol Macromol. 2015 Jan;72:1473-8. doi: 10.1016/j.ijbiomac.2014.09.063. Epub 2014 Oct 14.
4
Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques.通过反溶剂沉淀法和高压均质技术制得的结晶塞来昔布,Solupuls 对其有显著的溶出增强效果。
Colloids Surf B Biointerfaces. 2014 Oct 1;122:591-600. doi: 10.1016/j.colsurfb.2014.07.037. Epub 2014 Jul 31.
5
Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP.比较各种制备微米/纳米颗粒的技术,以提高含聚乙烯吡咯烷酮的塞来昔布的溶出度。
Eur J Pharm Biopharm. 2014 Sep;88(1):261-74. doi: 10.1016/j.ejpb.2014.05.022. Epub 2014 Jun 19.
6
Design and characterization of microcrystals for enhanced dissolution rate of celecoxib.用于提高塞来昔布溶解速率的微晶的设计与表征
Curr Drug Discov Technol. 2013 Dec;10(4):305-14. doi: 10.2174/15701638113109990035.
7
Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.制备稳定无定形纳米粒增强难溶性塞来昔布溶出度和生物利用度的机制。
J Pharm Pharm Sci. 2010;13(4):589-606. doi: 10.18433/j3530j.
8
Formulation and in vitro characterization of novel sildenafil citrate-loaded polyvinyl alcohol-polyethylene glycol graft copolymer-based orally dissolving films.新型载枸橼酸西地那非聚乙烯醇-聚乙二醇接枝共聚物基口腔崩解膜的配方及体外特性研究
Int J Pharm. 2014 Oct 1;473(1-2):398-406. doi: 10.1016/j.ijpharm.2014.07.037. Epub 2014 Jul 28.
9
Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.使用煅烧的镁铝水滑石提高塞来昔布无定形形式的稳定性。
Eur J Pharm Biopharm. 2007 May;66(2):253-9. doi: 10.1016/j.ejpb.2006.10.006. Epub 2006 Oct 17.
10
A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions.喷雾干燥和冷冻干燥的氢化可的松/聚乙烯吡咯烷酮固体分散体的比较研究。
Drug Dev Ind Pharm. 2011 Oct;37(10):1141-9. doi: 10.3109/03639045.2011.562213. Epub 2011 May 26.

引用本文的文献

1
Advancements in the Transdermal Drug Delivery Systems Utilizing Microemulsion-based Gels.利用微乳液凝胶的透皮药物传递系统的进展。
Curr Pharm Des. 2024;30(35):2753-2764. doi: 10.2174/0113816128305190240718112945.
2
Screening, Synthesis, and Characterization of a More Rapidly Dissolving Celecoxib Crystal Form.一种溶解更快的塞来昔布晶型的筛选、合成与表征
ACS Omega. 2024 Jun 27;9(27):29710-29722. doi: 10.1021/acsomega.4c03188. eCollection 2024 Jul 9.
3
Evaluation of a Three-Fluid Nozzle Spraying Process for Facilitating Spray Drying of Hydrophilic Polymers for the Creation of Amorphous Solid Dispersions.
用于促进亲水性聚合物喷雾干燥以制备无定形固体分散体的三流体喷嘴喷雾过程的评估
Pharmaceutics. 2023 Oct 27;15(11):2542. doi: 10.3390/pharmaceutics15112542.
4
Current Trends on Solid Dispersions: Past, Present, and Future.固体分散体的当前趋势:过去、现在和未来
Adv Pharmacol Pharm Sci. 2022 Oct 22;2022:5916013. doi: 10.1155/2022/5916013. eCollection 2022.
5
Celecoxib Loaded In-Situ Provesicular Powder and Its In-Vitro Cytotoxic Effect for Cancer Therapy: Fabrication, Characterization, Optimization and Pharmacokinetic Evaluation.塞来昔布原位成泡粉及其在癌症治疗中的体外细胞毒性作用:制备、表征、优化及药代动力学评价
Pharmaceutics. 2020 Nov 28;12(12):1157. doi: 10.3390/pharmaceutics12121157.
6
Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity.具有增强降压活性的厄贝沙坦二元分散体和纳米复合材料的研发。
Bioimpacts. 2020;10(4):269-278. doi: 10.34172/bi.2020.34. Epub 2019 Nov 25.
7
Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization.采用喷雾干燥或冷冻干燥法制备时,药物-固体分散体(Soluplus®)与药物-聚乙二醇6000分散体的体外性能差异研究。
Saudi Pharm J. 2017 Mar;25(3):419-439. doi: 10.1016/j.jsps.2016.09.013. Epub 2016 Sep 30.
8
Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.通过准乳液溶剂扩散法制备塞来昔布团聚体:稳定剂的影响
Adv Pharm Bull. 2016 Dec;6(4):607-616. doi: 10.15171/apb.2016.075. Epub 2016 Dec 22.
9
Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods.塞来昔布在固体分散体Solupuls®中的制备与表征:喷雾干燥法与传统方法的比较
Iran J Pharm Res. 2015 Winter;14(1):35-50.
10
Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.塞来昔布固体分散体的制备与表征;泊洛沙姆 188 与聚维酮 K30 作为载体的比较。
Iran J Basic Med Sci. 2014 May;17(5):322-31.